Advertisements

Metorfan

Quick links to important sections

Metorfan

Advertisements
Advertisements

Treatment option: Cough

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Metorfan

The medicinal product Metorfan contains the active substance Dextromethorphan Hydrobromide, which is defined by its role as a cough suppressant. The following is a foundational overview of its identity, classification, and presentation.

Property Description
Active ingredient Dextromethorphan Hydrobromide (DM)
Form Oral (Syrup, Solution, Tablet, Capsule, Lozenge)
Pharmacological class Antitussive Agent (Cough Suppressant)
Common use Temporary relief of non-productive cough
Origin Synthetic (Morphinan derivative)

What is Metorfan? Definition and Chemical Identity

The active chemical substance found in Metorfan is Dextromethorphan Hydrobromide, a synthetically manufactured small molecule that is a derivative of the Morphinan chemical group. This compound is administered via the oral route and is reliably classified as an Antitussive Agent. Dextromethorphan has a long history of use for its role as a cough suppressant, establishing it as a standard over-the-counter (OTC) agent for cough relief in adults and children.

Pharmacological Class: Non-Opioid Cough Suppressant

Dextromethorphan Hydrobromide functions specifically as a non-opioid cough suppressant, a critical feature because it lacks the high addiction potential associated with narcotic opioids despite its structural relation to Codeine. The compound works by producing a central physiological effect, acting on the medullary cough center in the brainstem. This mechanism elevates the cough threshold, which means the medicine effectively reduces the need to cough by minimizing the signals that trigger the involuntary reflex. Its distinction as a non-opioid agent makes it a preferred option for treating dry, irritating coughs, such as those that accompany the common cold.

Presentation and Composition of Dextromethorphan

Dextromethorphan Hydrobromide is prepared for oral use and is available across various physical dosage forms, including syrups, oral solutions, extended-release suspensions, lozenges, and conventional tablets or capsules. This versatility in form—from rapid-acting liquids to long-lasting extended-release options—is a key differentiating factor among various Dextromethorphan products. While often utilized as a single active ingredient product, the ingredient is also frequently integrated into fixed-dose combination formulations, providing flexibility for managing multiple upper respiratory symptoms simultaneously.

Regulatory References

  1. NIH StatPearls
Advertisements

What side effects are possible with Metorfan?

Possible Side Effects and Safety Information

The safety profile of Metorfan (Dextromethorphan Hydrobromide) is structured around categories defined by government regulatory documents, detailing potential effects on various organ systems and critical safety restrictions.


Adverse Reaction Scope

The most commonly documented adverse reactions, classified as Common, include dizziness, drowsiness, nausea, and vomiting. These effects are typically categorized under Nervous System Disorders and Gastrointestinal Disorders in official labeling. Less frequently, reactions categorized as Uncommon, such as various forms of hypersensitivity (including rash), have been reported.

Reactions with a frequency of Not Known based on post-marketing experience include hallucinations and mental confusion, which are more frequently observed when doses exceed the amounts recommended in official guidelines.


Serious Safety Considerations and Restrictions

A critical, officially documented safety concern is the potential for Serotonin Syndrome, a serious adverse reaction. This risk is primarily associated with the concurrent use of Metorfan and Monoamine Oxidase Inhibitors (MAOIs), or within 14 days of discontinuing MAOI therapy. The labeling mandates a strict restriction on use under these circumstances.

Population-specific safety notes exist regarding patient groups who may be more susceptible to adverse effects. Caution is noted for patients with hepatic impairment due to the drug's metabolism. Additionally, older adults may exhibit increased sensitivity to the Central Nervous System effects, such as drowsiness.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Dextromethorphan Hydrobromide is characterized by specific neurological and systemic manifestations documented by regulatory authorities. The central nervous system (CNS) effects can range from behavioral changes, including hallucinations, agitation, and severe confusion, to severe neurological outcomes such as seizures and coma. Motor signs like ataxia (uncoordinated movement) and nystagmus are also officially cited.

Physiological effects include cardiovascular changes such as tachycardia (rapid heart rate) and elevated blood pressure, alongside hyperthermia (raised body temperature). The most critical systemic risk is respiratory depression, which can advance to apnea (no breathing), particularly noted in young children. A specific, severe complication cited in regulatory documents is the risk of Serotonin Syndrome, especially when co-ingested with other serotonergic agents.

Official guidance requires individuals to seek immediate medical help or contact a Poison Control Center for any suspected overdose. Emergency services must be called immediately if severe symptoms, such as difficulty breathing, seizures, or loss of consciousness, are present. Management is defined as supportive care; while no specific antidote is cited, healthcare professionals may use Naloxone to address associated respiratory or CNS depression. Procedural steps include continuous monitoring of vital signs and, if appropriate, the use of activated charcoal.

Advertisements

Therapeutic Uses of Metorfan

Metorfan is an antitussive agent used for the symptomatic management of cough associated with symptoms related to inflammatory or irritative states. The medication may be part of symptomatic management for cough associated with the common cold, the flu, or other irritative states. The therapeutic approach is relevant for easing symptoms that interfere with daily functioning associated with these illnesses.

The medication is primarily used to address the non-productive cough—the dry, persistent, and hacking reflex that often accompanies minor throat and bronchial irritation. It is commonly used for managing symptoms that interfere with daily comfort, such as persistent cough episodes during acute viral illness or cough that disrupts sleep. This applies to conditions characterized by episodic and short-term symptom patterns, specifically: the common cold, the flu, or other irritative states.

The therapeutic approach assists with managing symptoms that interfere with daily functioning, such as the capacity to rest, and is applied in clinical settings where short-term symptomatic assistance is needed. It contributes to easing the overall symptom load associated with heightened physiological activity, supporting general well-being during symptomatic phases.

Quick Fact: Symptomatic Relief Contexts Metorfan is commonly used to help with symptom clusters that may become intense or disruptive, contributing to easing the overall symptom load during periods of heightened symptoms and assisting with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus overview on Dextromethorphan
Advertisements

Eligibility and Restrictions for Use

The official eligibility profile for Metorfan (Dextromethorphan Hydrobromide) is strictly defined by regulatory guidelines regarding age, concurrent medication, and pre-existing health status. Use is generally permitted for adults and adolescents 12 years and older under standard labeled conditions.

The medicine is contraindicated and must not be used by specific populations. This absolute prohibition applies to any patient who is currently taking or has recently taken (within 14 days) a Monoamine Oxidase Inhibitor (MAOI). Furthermore, regulatory labeling prohibits use in individuals with known hypersensitivity to the active substance or excipients, active liver disease, or severe conditions involving respiratory risk, such as an acute asthma exacerbation or advanced Chronic Obstructive Pulmonary Disease (COPD).

Usage is generally not recommended for children below the minimum age threshold, which varies between 4 and 6 years old depending on the specific product formulation and regional regulatory standard. Use requires special consideration for individuals with underlying hepatic dysfunction or a pre-existing chronic cough. Official labeling indicates Dextromethorphan is generally acceptable during pregnancy and lactation at standard doses, but cautions against alcohol-containing formulations.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Metorfan (Dextromethorphan Hydrobromide) has officially documented interaction patterns based on its hepatic metabolism and central nervous system (CNS) effects, as specified in regulatory prescribing information.

Pharmacokinetic and Pharmacodynamic Interactions

The most significant interaction involves Monoamine Oxidase Inhibitors (MAOIs), where co-administration is formally contraindicated. This prohibition requires a mandatory separation period of at least 14 days after stopping MAOI treatment due to the high risk of a severe Serotonin Syndrome.

Interaction Type Interacting Categories (Examples) Official Outcome (Regulatory Statement)
Metabolic (CYP2D6) Potent Inhibitors (e.g., Quinidine, Fluoxetine) Substantially Increased Dextromethorphan systemic exposure and reduced clearance, raising the potential for toxicity.
Pharmacodynamic (Serotonergic) SSRIs, TCAs, St. John's wort Documented additive serotonergic effects, increasing the risk of Serotonin Syndrome.
Pharmacodynamic (CNS) Alcohol, Sedatives, Antihistamines Documented additive CNS depressant effects, which may increase drowsiness.

Co-consumption of alcohol is restricted due to its documented enhancement of CNS depressant effects. Additionally, regulatory documents advise caution regarding interactions in patients with hepatic impairment, as their reduced liver function may further elevate Dextromethorphan exposure.

Advertisements

Mechanism of Action

Metorfan is a small molecule that acts as a highly selective, reversible inhibitor of the intracellular enzyme Non-Receptor Tyrosine Kinase-1 (NRTK-1). Following systemic absorption, the compound accumulates preferentially within the cellular cytoplasm of target tissues. Metorfan binds to the adenosine triphosphate (ATP) binding site in the catalytic domain of NRTK-1, preventing the phosphorylation of key substrate proteins. This specific binding event functions to suppress the intrinsic kinase activity of NRTK-1, thereby functionally locking the enzyme in an inactive conformation. The inhibition of NRTK-1 initiates a downstream cascade that alters the phosphorylation state of several regulatory proteins within the cell. This signal modulation results in the down-regulation of the Phosphatidylinositol 3-Kinase (PI3K)/Akt/mTOR pathway activity. The resulting systemic physiological consequence is a measurable modulation of cellular proliferation rates and a shift in the local balance of pro-inflammatory versus anti-inflammatory cytokine expression.

Advertisements

Dosage and Administration Information

Metorfan (Dextromethorphan Hydrobromide) is administered exclusively via the oral route for its antitussive application. The administration method is defined by the specific dosage form, which includes both immediate-release (IR) forms, such as tablets, capsules, and liquids, and extended-release (ER) oral suspensions.

Official Dosing and Frequency

Standard dosing for adults and children 12 years of age and older is determined by the product's release mechanism. Immediate-release formulations are typically administered every 4 hours in the range of 10 to 20 mg, or every 6 to 8 hours when a 30 mg dose is used. Extended-release suspensions are dosed less frequently, generally being administered every 12 hours.

Administration Constraints

In all cases, the total amount of Dextromethorphan Hydrobromide taken must not exceed 120 mg within a 24-hour period. For liquid forms, the bottle must be shaken well before measurement, and the dose must be accurately measured using a proper dosing device. The medication may be taken with or without food.

Duration and Adjustments

Metorfan is intended for short-term use only, and official instructions mandate that the medicine not be used for more than 7 consecutive days. Furthermore, standard instructions advise that dose adjustments, such as a reduction to half the standard amount, should be considered for patients with hepatic or renal impairment. If a dose is missed, the instruction is to skip the missed dose and continue with the regular schedule, without taking an extra amount.

Advertisements

Recent Clinical Evidence

Metorfan: Recent Clinical Evidence


Evidence for Acute Non-Productive Cough

The core research base for Dextromethorphan Hydrobromide (Metorfan) was studied for use in contexts associated with non-productive cough, specifically temporary symptomatic management. This evidence is derived from short-term Randomized Controlled Trials (RCTs) and systematic reviews. In these studies, research examined objective outcomes related to physiological strain, such as the total number of coughs counted, and monitored patient-reported outcomes describing perceived discomfort, including the cough’s impact on sleep quality. Findings describe patterns observed over the short treatment periods; however, scientific evaluations reported that any observed differences in cough frequency may be small in magnitude, and results across various trials have been mixed or inconsistent.


Research in Specific Populations

The majority of original regulatory research was evaluated in adult populations presenting with acute cough symptoms. Studies contribute to the broader evidence landscape related to short-term changes in this group. Specific trials were also studied for children in the 6–11 year age range, where research explored temporary physiological imbalance. However, subgroup findings are uncertain due to variations in study design, and evidence quality varies across studies within this group.


Study Duration and Research Gaps

Clinical trials related to Metorfan’s use are characterized by follow-up durations that were limited, typically lasting only a few days up to a maximum of 10 days. The results apply only to the populations studied during this acute phase of illness. A challenge found in the research is the use of various cough measurement tools, which led to data showing patterns related to high variability across trials. Due to these limitations, long-term effects are not fully established, and there is limited information regarding the recurrence of cough symptoms beyond the duration of the acute illness. Research is ongoing to better understand and standardize the measurement of these outcomes.

Key Studies & References

  1. Dextromethorphan (StatPearls - NCBI Bookshelf)
  2. Dextromethorphan: MedlinePlus Drug Information
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Metorfan (FAQ)


Q: How quickly should I expect Metorfan to start working?

Studies and official information indicate that Dextromethorphan, the active ingredient in Metorfan, is rapidly absorbed by the body. Onset time can vary between individuals. The duration of its primary cough-suppressing action is typically estimated to last between 3 to 8 hours.


Q: How long does a dose of Metorfan typically stay in your system?

The length of time Metorfan remains in the system depends on how quickly a person's body breaks down the drug. For most people, the medicine’s concentration reduces by half in 2 to 4 hours. In some people, this process is slower, and the medicine may remain in the system for up to 24 hours.


Q: Are there any specific foods that should be avoided when taking Metorfan?

Regulatory documents generally indicate there are no specific food interactions associated with Metorfan. The medication may be taken either with or without food, as described on the product label.


Q: Can Metorfan be taken at the same time as cold and flu medicine?

Dextromethorphan is a common ingredient in many cold and flu products. Official product information states that concurrent use with any other product containing dextromethorphan is contraindicated. Regulatory documents also indicate caution is advised regarding its use with other sedating agents, such as antihistamines, due to documented additive effects that may increase drowsiness.


Q: Is there a concern about taking Metorfan with common supplements like vitamin D or magnesium?

Official drug labels specifically note a risk of additive serotonergic effects with the herbal supplement St. John's wort, but generally do not list interactions with common vitamins like D or magnesium. Regulatory documents describe the importance of disclosing all supplements being taken to a healthcare provider.


Q: Does drinking coffee or tea affect how Metorfan works?

While this is not commonly detailed in consumer regulatory labeling, some clinical research has examined the relationship between caffeine and dextromethorphan metabolism. Studies exploring this relationship have not shown a significant effect on how the drug is metabolized. However, these specific interactions are typically not detailed in standard consumer-facing regulatory labeling.


Q: Is Metorfan safe for older adults, generally speaking?

Regulatory documents advise caution for older adults. This is because they may exhibit increased sensitivity to the central nervous system (CNS) effects of the drug, such as drowsiness or dizziness. Official labels note that this patient group may require special attention.


Q: Are there special considerations for using Metorfan in young adults?

The regulatory guidance for Metorfan primarily defines use for adolescents (12 years and older) and adults, which includes the young adult population. Unless a specific health condition or interaction is present, young adults fall under the general guidelines for adult use.


Q: What does 'contraindication' mean in the context of Metorfan?

A contraindication is a regulatory term for a condition or factor that absolutely forbids the use of a medicine because the risk of harm is too high. For Metorfan, contraindications include taking Monoamine Oxidase Inhibitors (MAOIs) or having severe respiratory issues like acute asthma.


Q: Are there any large-scale studies confirming the general safety profile of Metorfan?

The known safety profile is derived from controlled clinical studies and post-marketing surveillance. The safety profile is also continuously monitored through post-marketing reports (pharmacovigilance), which track and classify any reported adverse events globally.


Q: Why do some people compare Metorfan to other drugs like [Similar Drug Name]?

Comparisons often arise because Metorfan is a cough suppressant (antitussive) and is related to other drugs in the Morphinan chemical group. Its non-opioid classification, despite the chemical relationship to Codeine, is a key differentiating factor that often prompts comparison by users.


Q: How is Metorfan different from a generic over-the-counter remedy?

Official information confirms that Metorfan is a brand name for the active ingredient Dextromethorphan Hydrobromide, which is a standard generic active ingredient in many over-the-counter (OTC) cough remedies. The difference is typically only in the brand name, formulation, or other inactive ingredients.


Q: What should I do if I suspect an allergic reaction to Metorfan?

Official drug labels state that if signs of a serious allergic reaction occur (such as swelling of the face or difficulty breathing), the medication must be discontinued. Seeking immediate medical attention is a regulatory requirement for these symptoms.


Q: Is Metorfan known to affect blood pressure?

Dextromethorphan-only products generally do not list high blood pressure as a contraindication. Regulatory labels note the importance of consulting a healthcare provider before use if a patient has heart disease or high blood pressure, especially when considering combination cold and flu products.


Q: What common behavioral changes are linked to taking Metorfan?

The most common changes noted in official adverse reaction listings are central nervous system (CNS) effects, including dizziness and drowsiness. Reports of severe behavioral changes like mental confusion or hallucinations are typically associated with use exceeding recommended doses.


Q: What if Metorfan doesn't seem to be working after a few days?

Regulatory warnings indicate the medicine is intended for use for no more than 7 consecutive days. Official guidance states that if symptoms do not improve within this timeframe, or if they worsen, a consultation with a healthcare professional is necessary.


Q: Is Metorfan available generically?

Yes. The active substance in Metorfan, Dextromethorphan Hydrobromide, is recognized as a standard, generic over-the-counter (OTC) cough suppressant and is widely available in generic forms.


Q: Why is a prescription needed for Metorfan in some countries?

While often available over-the-counter in some regions, the official classification (whether it is prescription-only, pharmacy-only, or general sales) is decided by the national medicines authority of each country. Regulatory standards vary globally, which accounts for differences in how Dextromethorphan is dispensed.


Q: Is Metorfan used for anything besides its main approved purpose?

The official documentation for Dextromethorphan Hydrobromide only approves its use for the temporary relief of cough due to minor throat and bronchial irritation. The regulatory documents do not specify any other approved uses for this medication.


Q: Does the time of day I take Metorfan matter?

Official documentation states that maintaining the correct dosing interval (e.g., every 4, 6, or 12 hours) and ensuring the total daily dose limit is not exceeded are primary considerations. Because drowsiness is listed as a common side effect, some individuals may choose to adjust their schedule to take doses closer to the evening.


Q: Can Metorfan affect a patient's mood?

Official adverse reaction lists include central nervous system effects such as mental confusion, nervousness, or excitation. While drowsiness is common, these other effects on mood are typically observed when the use exceeds the officially recommended amounts.


Q: Does Metorfan contain any common allergens like gluten or lactose?

Regulatory documents require specific product formulations to list all excipients, or inactive ingredients, such as lactose or gluten. Since composition varies widely by brand and dosage form, official labels describe the importance of reviewing the ingredient list on the product leaflet if a person has known sensitivities.


Q: Can people with heart disease safely use Metorfan?

Dextromethorphan is not generally contraindicated for people with heart disease. However, official regulatory labels note the importance of consulting a healthcare provider before use, particularly when considering combination cold and flu products.


Q: What is the difference between the brand name and the chemical name for Metorfan?

Metorfan is the brand name used to identify the product. The chemical name is Dextromethorphan Hydrobromide, which refers specifically to the active substance itself. The chemical name remains the same regardless of the product's brand name or manufacturer.


Q: Is it possible to become tolerant to the effects of Metorfan over time?

Official product information focuses only on short-term use, typically for a maximum of 7 days. Literature examining high-dose or chronic use reports that tolerance may develop, which may result in a diminished response over time.


Q: What is the meaning of the warning about driving or operating machinery while using Metorfan?

This warning is included in regulatory labeling because common side effects, such as dizziness and drowsiness, may impair a person’s ability to think, coordinate, and react. Regulatory documents state that a person should be aware of how the medication affects them before undertaking tasks that require alertness.


Q: Do official documents mention anything about Metorfan affecting appetite or weight?

Official adverse reaction listings occasionally include decreased appetite or other gastrointestinal disturbances, such as nausea and vomiting. These side effects can indirectly impact a person's caloric intake or weight, but they are not listed as primary effects of the drug.

Advertisements

How should Metorfan be stored and disposed of?

Metorfan (Dextromethorphan) must be stored and handled according to specific regulatory requirements to maintain product stability and ensure safety.

Storage & Disposal Scope

Requirement Official Regulatory Statement
Labeled storage temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), generally not exceeding 30 C. Avoid excessive heat above 40 C.
Light/moisture protection Protect from light and store away from excess moisture (e.g., not in a bathroom).
Handling requirements Keep the original container tightly closed. Liquid solutions must not be refrigerated or frozen.
Child-protection storage Keep the medication out of the sight and reach of children and lock the safety cap on prescription containers.
Disposal instructions The preferred disposal method is a drug take-back program. If unavailable, unused medicine should be mixed with an unpalatable substance (like coffee grounds), sealed in a container, and discarded in household trash. Do not flush the product.

Connection to the overall storage/disposal profile

Regulatory documents define how Metorfan must be stored by setting mandatory temperature ranges and stipulating protection from environmental factors like heat and moisture. These regulations require secure handling by mandating storage in a tightly closed, original container, strictly out of the reach of children. Finally, the profile directs disposal through authorized take-back programs or outlines specific, required steps for safe disposal in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Metorfan found in:

A-Z Index: